New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.
Category:
Published on: 31 Mar 2025
With Halloween approaching, McGill University experts are available to offer insights on a range of related topics.
Category:
Published on: 25 Oct 2024
A new study published in Current Biology reveals the nanostructure of brain cells at an unprecedented level of resolution.
Published on: 7 Mar 2023
Lung cancer is the leading cause of cancer-related deaths in Quebec and Canada, killing more individuals than prostate, colon and breast cancers combined. Thanks to tissue samples from almost 500 lung cancer patients, a group of researchers from McGill University and Université Laval were able to identify those who were likely to have a cancer recurrence and require further treatment post-surgery.
Category:
Published on: 2 Feb 2023
New funding of $5.1 million from the Canada Foundation for Innovation (CFI), announced today by the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will help researchers Marcel Behr, MD, PhD, and Silvia Vidal, PhD, ensure that Canada is better prepared for the next pandemic. This funding is part of the more than $127 million investment being made through the CFI to support upgrades to eight biocontainment facilities across the country as part of its new Biosciences Research Infrastructure Fund (BRIF) program.
Category:
Published on: 16 Nov 2022
When an Indigenous patient receiving treatment at the MUHC refused to eat, McGill MScA candidate Manveen Sethi was enlisted to find an authentic recipe for Bannock bread, a traditional Indigenous snack. Through research and with the help of Indigenous patients who taste-tested recipes, Sethi found a recipe that will now be permanently available on the MUHC menu and hopefully offer a little comfort to Indigenous patients being treated at the facility.
Published on: 6 Oct 2022
Despite high hopes, a new pan-Canadian study published today in The BMJ suggests that ciclesonide—an inhaled and nasal steroid drug commonly used for asthma and rhinitis—won’t be the treatment to change the course of the pandemic.
Category:
Published on: 2 Nov 2021
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
Source: RI-MUHC
Published on: 3 Jun 2021
Finding could lead to potential therapies
Published on: 14 Dec 2020
Heart & Stroke and McGill University to create Early-Career Professorship in Women’s Heart Health
Montréal, June 18, 2019 – The first research chair in Quebec focused on women’s cardiac health, propelled by Heart & Stroke and McGill University, will officially be launched on July 1 via a research project led by Dr. Natalie Dayan, Assistant Professor of Medicine at McGill University’s Faculty of Medicine and Director of Obstetrical Medicine in the division of General Internal Medicine at the McGill University Health Centre (MUHC).
Category:
Published on: 18 Jun 2019
New research from McGill University has found that a virus infecting the Leishmania parasite spreads by exploiting a mechanism used for cell-to-cell communication, a discovery that could pave the way to new vaccines against infections that cause severe disfiguration.
Category:
Published on: 7 Feb 2019
Category:
Published on: 3 Jan 2019
A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI’s so-called “Dr. House” because of his research into rare diseases, has discovered a new human disease and the gene responsible for it, paving the way for the proper diagnosis of patients globally and the development of new therapies. Their findings are published in the Journal of Experimental Medicine.
Category:
Published on: 6 Dec 2018
HIV self-testing strategies have been recommended by the World Health Organization (WHO) since 2016, as they empower people to find out HIV their status at their convenience. However, home-based testing kits have yet to be approved for sale in Canada.
Category:
Published on: 30 Nov 2018
The Research Institute of the McGill University Health Centre’s (RI-MUHC) push to treat a rare genetic disease in children – with a higher percentage found in French Canadians – has received $2 million as part of a national genomic contest led by Genome Canada.
Category:
Published on: 4 Oct 2018
Pages
